BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease

被引：3
|
作者：
Hagen, Melanie [1 ]
Bucci, Laura [1 ]
Boeltz, Sebastian [1 ]
Noethling, Danae-Mona [1 ]
Rothe, Tobias [1 ]
Anoshkin, Kirill [1 ]
Raimondo, Maria G. [1 ]
Tur, Carlo [1 ]
Wirsching, Andreas [1 ]
Wacker, Jochen [1 ]
Duesing, Christina [2 ]
Distler, Jorg H. W. [2 ]
Kuwert, Torsten [1 ]
Bozec, Aline [1 ]
Ramming, Andreas [1 ]
Schett, Georg [1 ]
Grieshaber-Bouyer, Ricardo [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nuremberg, Erlangen, Germany
[2] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 09期
关键词：
D O I：
10.1056/NEJMc2408786
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：867 / 869
页数：3
相关论文
共 50 条
  • [31] T cell targeted immunotherapy for autoimmune disease
    Lee, E
    Sinha, AA
    AUTOIMMUNITY, 2005, 38 (08) : 577 - 596
  • [32] Bilateral anterior cerebral artery occlusion following CD19- and BCMA-targeted chimeric antigen receptor T-cell therapy for a myeloma patient
    Li-xia Wang
    Xian-qiu Yu
    Jiang Cao
    Yi-long Lu
    Ming Luo
    Fang Lei
    Yu Tang
    Xiao-ming Fei
    International Journal of Hematology, 2021, 114 : 408 - 412
  • [33] Bilateral anterior cerebral artery occlusion following CD19-and BCMA-targeted chimeric antigen receptor T-cell therapy for a myeloma patient
    Wang, Li-xia
    Yu, Xian-qiu
    Cao, Jiang
    Lu, Yi-long
    Luo, Ming
    Lei, Fang
    Tang, Yu
    Fei, Xiao-ming
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (03) : 408 - 412
  • [34] Clinical Outcomes and Salvage Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Progression on BCMA-Targeted CAR-T Therapy
    Reyes, Kevin R.
    Liu, Yen-Chun
    Huang, Chiung-Yu
    Banerjee, Rahul
    Martin, Thomas
    Shah, Nina
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Arora, Shagun
    Chung, Alfred
    BLOOD, 2022, 140
  • [35] Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector
    Smith, Eric L.
    Staehr, Mette
    Masakayan, Reed
    Tatake, Ishan J.
    Purdon, Terence J.
    Wang, Xiuyan
    Wang, Pei
    Liu, Hong
    Xu, Yiyang
    Garrett-Thomson, Sarah C.
    Almo, Steven C.
    Riviere, Isabelle
    Liu, Cheng
    Brentjens, Renier J.
    MOLECULAR THERAPY, 2018, 26 (06) : 1447 - 1456
  • [36] Overcoming Challenges: Development of Two Potent, Domestic BCMA-targeted CAR-T Cell Products for the Treatment of Multiple Myeloma in Brazil
    Suzuki, Caroline
    Mitsugi, Thiago
    Andrade, Gislaine
    Vidal, Erica
    Barros, Cleyson
    Zanetti, Larissa
    Azevedo, Julia
    Paiva, Raquel
    Okamoto, Oswaldo
    Hamerschlak, Nelson
    Kerbauy, Lucila
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S91 - S91
  • [37] Therapeutic Potential of Imvotamab, a CD20-Targeted Bispecific IgM T Cell Engager, for the Treatment of Refractory Autoimmune Disease Patients
    Domingo-Gonzalez, Racquel
    Baribaud, Isabelle
    Oyasu, Miho
    Pandey, Sivani
    Leabman, Maya
    Hernandez, Genevive
    Candia, Albert
    Carroll, Stephen
    Keyt, Bruce
    Kotturi, Maya
    Brodmerkel, Carrie
    Harler, Mary Beth
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1152 - 1153
  • [38] Single-Cell Profiling Reveals Contribution of Tumor Extrinsic and Intrinsic Factors to BCMA-Targeted CAR-T Cell Efficacy in Multiple Myeloma
    Melnekoff, David T.
    Ghodke-Puranik, Yogita
    Van Oekelen, Oliver
    Aleman, Adolfo
    Upadhyaya, Bhaskar
    Sebra, Robert
    Jagannath, Sundar
    Lagana, Alessandro
    Parekh, Samir
    BLOOD, 2021, 138
  • [39] Clinical Outcomes and Treatment Strategies for Relapsed/Refractory Myeloma Patients after Relapse on BCMA-Targeted CAR T
    Van Oekelen, Oliver
    Mouhieddine, Tarek H.
    Pan, Darren
    Metzger, Megan
    Agte, Sarita
    Aleman, Adolfo
    Melnekoff, David T.
    Lancman, Guido
    Lagana, Alessandro
    Richard, Shambavi
    Sanchez, Larysa
    Richter, Joshua
    Cho, Hearn Jay
    Chari, Ajai
    Jagannath, Sundar
    Parekh, Samir
    BLOOD, 2021, 138
  • [40] Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective study
    Zheng, Haiqiong
    Han, Shi
    Chen, Yijin
    Zhao, Houli
    Chen, Rongrong
    Zhang, Qiqi
    Kong, Delin
    Zhang, Mingming
    Hu, Yongxian
    Huang, He
    BONE MARROW TRANSPLANTATION, 2025,
12345